Pharmacokinetics, safety, efficacy and immunogenicity of Adalimumab biosimilar ABP-501in rheumatoid arthritis and plaque psoriasis
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.
Main Author: | Akter, Anika |
---|---|
Other Authors: | Alam, Marzia |
Format: | Thesis |
Language: | English |
Published: |
Brac University
2022
|
Subjects: | |
Online Access: | http://hdl.handle.net/10361/17039 |
Similar Items
-
Biologics and Biosimilars as Treatment Options for Psoriasis
by: Moya, Amena Khatun
Published: (2023) -
Importance of biologics in rheumatoid arthritis management
by: Riyadh, S. M.
Published: (2022) -
TNF-α inhibitor-induced alopecia in psoriatic disease patients: a pharmacovigilance study
by: Afroza, Halima
Published: (2024) -
Importance of biologically active agents over other therapies in Rheumatoid Arthritis- a review
by: Mehreen, Elnaj
Published: (2021) -
A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis
by: Islam, Nahidul
Published: (2023)